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The sunscreen active ingredients benzophenone-3 (BP-3),
octyl-methoxycinnamate (OMC) and 3-(4-methylbenzyli-
dene) camphor (4-MBC) have previously been reported to
have estrogenic effects on cultured human breast cancer
cells and, in the case of 4-MBC, also in the immature rat
uterus in vivo (Schlumpf et al, 2001), raising the question of
whether these compounds are safe to apply topically to
humans. In this issue of the Journal, Janjua and colleagues
report that generous daily whole-body applications (2 mg
per cm2, approximately 40 g) of a formulation containing
maximal to twice maximal legally permitted concentrations
of these three sunscreen agents in combination result in
detectable plasma and urine levels in both young men and
post-menopausal women, but have minimal to no effect on
serum concentrations of reproductive hormones in either
sex (Janjua et al, 2004). Four of 11 serum measurements
(six in men, five in women) showed small but statistically
significant differences between the first control week when
subjects applied only the vehicle formulation, compared to
the test week that followed, when they applied the combi-
nation sunscreen product. In two of these four instances,
however, the differences were as large at time 0, before
application of the test product, as at any later time during
the week of daily sunscreen applications. This raises the
possibility that the regimen with which the subjects agreed
to comply—no exercise or sunbathing, and no ingestion of
caffeine, alcohol, or nicotine—during the trial might have
had at least as profound an effect on sex hormone status as
the sunscreen applications.
The authors conclude that regular use of this super-sun-
screen, and presumably all commercially available products
that contain far less of the tested substances, should be
quite safe for human use, although they express theoretic
concern for use in small children with their possibly less
adequate stratum corneum barrier, higher surface to volume
ratio, and greater sensitivity to hormone exposure. Certain-
ly, to this reader, it would appear that consumers should be
less concerned about estrogen exposure from sunscreen
than from McDonald’s hamburgers. And, at least to date, no
one has suggested that sunscreens cause obesityybut this
has not yet been formally tested.
Perhaps a more interesting question than whether sun-
screens pose a risk to sex hormone homeostasis is why
there is such a continued effort to find harm in sunscreen
use. For many years, there was a preoccupation with
whether sunscreens were mutagenic and could cause can-
cer (Dunkel et al, 1992; Chetelat et al, 1993). A second
loosely reasoned but long-standing concern has been that
use of predominantly UVB sunscreens might promote pho-
toaging and even melanoma by permitting greater UVA ex-
posure (Garland et al, 1993; Autier et al, 1995; Westerdahl
et al, 2000). More recently an alarm has been raised that
sunscreen use causes hypertension, autoimmune diseases
ranging from multiple sclerosis to diabetes, and cancer of
multiple internal organs by blocking cutaneous vitamin D
photosynthesis, on the rationale that vitamin D deficiency
impairs cellular differentiation and immune function (Holick
and Jenkins, 2003). And now the specters of precocious
puberty, male infertility, and risks of hormone supplemen-
tation in post-menopausal women are raised.
Sunscreen use was first promoted as preventive medi-
cine more than a half century ago (Lim et al, 2004). The
pharmaceutical and cosmetic industries have responded to
the evident public health need and pleas of the dermatology
community by developing highly effective sunscreen prod-
ucts with a superb safety record (Lim et al, 2004). Today’s
consumer can choose from a wide array of formulations and
sun protection factors (SPFs); if desired, he/she can readily
identify a product that offers very broad spectrum protec-
tion and is highly substantive and/or cosmetically elegant.
As the skin cancer and melanoma epidemics have pro-
gressed, the public has gradually begun to accept the
compelling evidence that excessive sun exposure destroys
the health and appearance of skin (Montague et al, 2001).
Cautionary messages abound, however, and sunscreens
seem always to remain under a small gray cloud, awaiting
the next assault on their safety and efficacy.
Personally, I’ll skip the hamburger, apply the sunscreen,
and recommend that my patients do the same.
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